Current practice of peritoneal dialysis in children: Results of a longitudinal survey

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Schaefer, Franz ^a   Klaus, Günter ^a   Müller Wiefel, Dirk E ^a   Mehls, Otto ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Adequacy; Children; Hypertension; Peritonitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; BICARBONATE; CREATININE; GROWTH HORMONE; IRON; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; UREA;

ANEMIA; ANTIHYPERTENSIVE THERAPY; BODY HEIGHT; BODY MASS; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; GROWTH RETARDATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALNUTRITION; PERITONEAL CATHETER; PERITONITIS; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 0033395807     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901902s73     Document Type: Conference Paper

References (8)

1. Schaefer F, Wolf S, Klaus G, Müller-Wiefel DE, Mehls O, and the Mid European Pediatric CPD Study Group. High Kt/V urea, associated with greater protein catabolic rate and dietary protein intake, in children treated with CCPD compared to CAPD. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10:310-14.
2. Schaefer F, and the Mid European Pediatric CAPD/ CCPD Study Group. Use of peritoneal equilibration test, small or middle molecule clearances and urea kinetic modeling to define the adequacy of peritoneal dialysis in children: Experience in a large pediatric population [Abstract]. Pediatr Nephrol. 1994; 8:C34.
3. Klaus G, Schaefer F, Müller-Wiefel DE, Mehls O, and members of APN. Treatment of peritoneal-dialysis -associated peritonitis with continuous vs. intermittent vancomycin/teicoplanin and ceftazidime in children: Preliminary results of a prospective, randomized trial. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11:296-301.
4. Schaefer F, Haraldsson B, Haas S, Feber J, Simkova E, Mehls O. Estimation of peritoneal mass transport by three-pore model in children. Kidney Int. 1998; 54:1352-9
5. Schaefer F, Klaus G, Müller-Wiefel DE, Mehls O, and the Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Randomised trial of intermittent vs. continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. J Am Soc Nephrol. 1999; 10:136-45.
6. Lupo A, Tarchini R, Cancarini G, Catizone L, Cocchi R, De Vecchi A, et al. Long-term outcome in continuous ambulatory peritoneal dialysis: A 10-year-survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis. 1994; 24:826-37.
7. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int. 1993; 40(Suppl):S4-15.
8. National Kidney Foundation Dialysis Outcomes Quality Initiative. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 1997; 30(Suppl 2):S67-136.